[HTML][HTML] Cyclosporine before PCI in patients with acute myocardial infarction
…, P Guérin, M Elbaz, N Delarche, P Coste… - … England Journal of …, 2015 - Mass Medical Soc
Background Experimental and clinical evidence suggests that cyclosporine may attenuate
reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine …
reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine …
[HTML][HTML] Bivalirudin started during emergency transport for primary PCI
…, P Clemmensen, F Lapostolle, P Coste… - … England Journal of …, 2013 - Mass Medical Soc
Background Bivalirudin, as compared with heparin and glycoprotein IIb/IIIa inhibitors, has
been shown to reduce rates of bleeding and death in patients undergoing primary …
been shown to reduce rates of bleeding and death in patients undergoing primary …
Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment–elevation …
N Danchin, P Coste, J Ferrières, PG Steg, Y Cottin… - Circulation, 2008 - Am Heart Assoc
Background— Intravenous thrombolysis remains a widely used treatment for ST-elevation
myocardial infarction; however, it carries a higher risk of reinfarction than primary PCI (PPCI). …
myocardial infarction; however, it carries a higher risk of reinfarction than primary PCI (PPCI). …
Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated …
…, W Huang, K Carruthers, T Simon, P Coste… - BMJ open, 2014 - bmjopen.bmj.com
Objectives Risk scores are recommended in guidelines to facilitate the management of patients
who present with acute coronary syndromes (ACS). Internationally, such scores are not …
who present with acute coronary syndromes (ACS). Internationally, such scores are not …
Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French …
…, T Simon, G Cayla, Y Cottin, M Elbaz, P Coste… - Circulation, 2017 - Am Heart Assoc
Background: ST-segment–elevation myocardial infarction (STEMI) and non–ST-segment–elevation
myocardial infarction (NSTEMI) management has evolved considerably over the …
myocardial infarction (NSTEMI) management has evolved considerably over the …
[HTML][HTML] Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a …
J Mesnier, Y Cottin, P Coste, E Ferrari… - The Lancet Public …, 2020 - thelancet.com
Background The COVID-19 pandemic has had a profound effect on general health care. We
aimed to evaluate the effect of a nationwide lockdown in France on admissions to hospital …
aimed to evaluate the effect of a nationwide lockdown in France on admissions to hospital …
Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study
…, J Vojacek, M Barboteu, JP Collet, P Coste… - European heart …, 2014 - academic.oup.com
Aims We aimed to assess the impact of eplerenone on cardiovascular (CV) outcomes in
STEMI without known heart failure, when initiated within 24 h of symptom onset. Methods and …
STEMI without known heart failure, when initiated within 24 h of symptom onset. Methods and …
Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial …
…, L Bonello, M Hanssen, H Lardoux, P Coste… - Circulation, 2011 - Am Heart Assoc
Background— Clopidogrel requires metabolic activation by cytochrome P450 2C19 (CYP2C19).
Proton pump inhibitors (PPIs) that inhibit CYP2C19 are commonly coadministered with …
Proton pump inhibitors (PPIs) that inhibit CYP2C19 are commonly coadministered with …
Five-year survival in patients with ST-segment–elevation myocardial infarction according to modalities of reperfusion therapy: the French registry on acute ST …
…, L Belle, Y Cottin, J Fajadet, K Khalife, P Coste… - Circulation, 2014 - Am Heart Assoc
Background— Although primary percutaneous coronary intervention (pPCI) is the preferred
reperfusion method for ST-segment–elevation myocardial infarction, it remains difficult to …
reperfusion method for ST-segment–elevation myocardial infarction, it remains difficult to …
Fibrinolysis of mechanical prosthetic valve thrombosis: a single-center study of 127 cases
…, JM Perron, C Jaïs, X Pillois, P Coste… - Journal of the American …, 2003 - jacc.org
Objectives : This study was designed to analyze the results of fibrinolytic treatment (FT) in a
large single-center group of patients with prosthetic heart valve thrombosis (PHVT). …
large single-center group of patients with prosthetic heart valve thrombosis (PHVT). …